Reaktion #660191

ord-ef778fdf66234a938fc7a77d2a57027f

Lösungsmittel

Reaktionsbedingungen

Temperatur
0°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturThe reaction mixture was then cooled back to −78° C.
  2. 2
    TemperaturThe batch was heated to 0° C.
  3. 3
    workup.STIRRINGstirred further for three hours at this temperature
  4. 4
    SonstigeThe reaction was then terminated
  5. 5
    workup.ADDITIONby adding saturated aqueous ammonium chloride solution
  6. 6
    workup.ADDITIONThe mixture was diluted with MTBE
  7. 7
    Sonstigethe phases were separated
  8. 8
    Trocknenthe organic phase was dried over magnesium sulfate
  9. 9
    Einengenconcentrated in vacuo
  10. 10
    SonstigeThe residue was purified over a silica gel column
  11. 11
    EinengenAfter concentrating the corresponding fractions, 173 mg (25.6% of the theoretical) of the Boc-

Vorschrift

Under argon, 842 μL (2.1 mmol) 2.5 M n-butyllithium solution in hexane was added to a suspension of 986 mg (2.2 mmol) triphenyl-(2-phenylethyl)phosphonium bromide [can be synthesized, e.g., according to R. W. Hartmann, M. Reichert, Archiv der Pharmazie 333, 145 (2000); K. C. Nicolaou et al., European J. Chem. 1, 467 (1995)] in 125 mL THF at −78° C., and the mixture was then stirred for one hour at 0° C. The reaction mixture was then cooled back to −78° C. and a solution of 500 mg (2.0 mmol) tert-butyl-[(2S)-1-oxo-3-phenylpropan-2-yl]carbamate in 5 mL dry THF was added. The batch was heated to 0° C. and stirred further for three hours at this temperature. The reaction was then terminated by adding saturated aqueous ammonium chloride solution. The mixture was diluted with MTBE, the phases were separated, and the organic phase was dried over magnesium sulfate and concentrated in vacuo. The residue was purified over a silica gel column using cyclohexane/ethyl acetate 5:1 as the mobile phase. After concentrating the corresponding fractions, 173 mg (25.6% of the theoretical) of the Boc-protected intermediate, tert-butyl-[(2S,3Z)-1,5-diphenylpent-3-en-2-yl]carbamate was obtained.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09029406B2uspto-grants-2015_05